Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
Divya Teli, Mamta B. Shah, Mahesh T. Chhabria
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
Gabriele La Monica, Alessia Bono, Antonino Lauria, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 12500-12534
Open Access | Times Cited: 98
Antimicrobial Activity of Curcumin in Nanoformulations: A Comprehensive Review
Jeffersson Krishan Trigo-Gutierrez, Yuliana Vega-Chacón, Amanda Brandão Soares, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7130-7130
Open Access | Times Cited: 95
Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
Rafat Zrieq, Iqrar Ahmad, Mejdi Snoussi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10693-10693
Open Access | Times Cited: 79
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis
Normi D. Gajjar, Tejas M. Dhameliya, Gaurang Shah
Journal of Molecular Structure (2021) Vol. 1239, pp. 130488-130488
Open Access | Times Cited: 73
Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
Shafi Mahmud, Suvro Biswas, Gobindo Kumar Paul, et al.
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 9, pp. 103315-103315
Open Access | Times Cited: 69
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds
Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1306-1344
Open Access | Times Cited: 65
Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia
Sachiko Koyama, Kenji Kondo, Rumi Ueha, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8912-8912
Open Access | Times Cited: 62
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2
Fangfang Yan, Feng Gao
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4868-4883
Open Access | Times Cited: 49
Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets
Shafi Mahmud, Mohasana Akter Mita, Suvro Biswas, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 10, pp. 1305-1315
Closed Access | Times Cited: 44
In silico validation of anti-viral drugs obtained from marine sources as a potential target against SARS-CoV-2 Mpro
Srijit Ghosh, Srijita Das, Iqrar Ahmad, et al.
Journal of the Indian Chemical Society (2021) Vol. 98, Iss. 12, pp. 100272-100272
Closed Access | Times Cited: 42
Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection
Rui Ge, Zuyuan Shen, Jian Yin, et al.
SLAS DISCOVERY (2022) Vol. 27, Iss. 2, pp. 79-85
Open Access | Times Cited: 33
Design, synthesis and bioevaluation of 1,2,4-thiadiazolidine-3,5-dione derivatives as potential GSK-3β inhibitors for the treatment of Alzheimer's disease
Yong‐Xi Dong, Jun Lü, Shanhui Zhang, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106446-106446
Closed Access | Times Cited: 16
In Silico Binding Role of Flavonoids as SARS-CoV-2 Main Protease (Mpro) Inhibitors: A Dataset of Molecular Docking Simulation-Based High-Throughput Virtual Screening (HTVS)
Mariyam Eema, Vasudeva Rao Avupati
Data in Brief (2025), pp. 111308-111308
Open Access
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
Noor Atatreh, Radwa E. Mahgoub, Mohammad A. Ghattas
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis
Von Novi O. de Leon, Joe Anthony Manzano, Delfin Yñigo H. Pilapil, et al.
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 104-104
Open Access | Times Cited: 33
Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19
Le-le Ma, Huimin Liu, Xuemei Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113857-113857
Open Access | Times Cited: 33
In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer
Muruganantham Bharathi, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Marine Drugs (2022) Vol. 20, Iss. 2, pp. 148-148
Open Access | Times Cited: 24
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
In Silico Analysis Reveals the Inhibitory Potential of Madecassic Acid against Entry Factors of SARS-CoV-2
Abhratanu Ganguly, Moutushi Mandi, Anik Dutta, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 2, pp. 652-662
Closed Access | Times Cited: 14
Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
Vivek P. Chavda, Divya Teli, Pankti C. Balar, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2332-2332
Open Access | Times Cited: 13
Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape
Anand Krishnan, Senthilkumar Muthusamy, Francis Fernandez, et al.
Tissue Engineering and Regenerative Medicine (2022) Vol. 19, Iss. 4, pp. 659-673
Open Access | Times Cited: 21
Integrated network pharmacology analysis, molecular docking, LC-MS analysis and bioassays revealed the potential active ingredients and underlying mechanism of Scutellariae radix for COVID-19
Jiazheng Liu, Jieru Meng, Runfeng Li, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 18
In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2
Jeffry Medina-Barandica, Neyder Contreras‐Puentes, Arnulfo Tarón-Dunoyer, et al.
Informatics in Medicine Unlocked (2023) Vol. 40, pp. 101278-101278
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top